183 related articles for article (PubMed ID: 18854428)
1. Changes in insulin sensitivity during leptin replacement therapy in leptin-deficient patients.
Paz-Filho G; Esposito K; Hurwitz B; Sharma A; Dong C; Andreev V; Delibasi T; Erol H; Ayala A; Wong ML; Licinio J
Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1401-8. PubMed ID: 18854428
[TBL] [Abstract][Full Text] [Related]
2. Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy.
Lee JH; Chan JL; Sourlas E; Raptopoulos V; Mantzoros CS
J Clin Endocrinol Metab; 2006 Jul; 91(7):2605-11. PubMed ID: 16636130
[TBL] [Abstract][Full Text] [Related]
3. The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients.
Musso C; Cochran E; Javor E; Young J; Depaoli AM; Gorden P
Metabolism; 2005 Feb; 54(2):255-63. PubMed ID: 15690321
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic use of recombinant methionyl human leptin.
Vatier C; Gautier JF; Vigouroux C
Biochimie; 2012 Oct; 94(10):2116-25. PubMed ID: 22464954
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults.
Licinio J; Caglayan S; Ozata M; Yildiz BO; de Miranda PB; O'Kirwan F; Whitby R; Liang L; Cohen P; Bhasin S; Krauss RM; Veldhuis JD; Wagner AJ; DePaoli AM; McCann SM; Wong ML
Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4531-6. PubMed ID: 15070752
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of recombinant methionyl human leptin therapy for the extreme insulin resistance of the Rabson-Mendenhall syndrome.
Cochran E; Young JR; Sebring N; DePaoli A; Oral EA; Gorden P
J Clin Endocrinol Metab; 2004 Apr; 89(4):1548-54. PubMed ID: 15070911
[TBL] [Abstract][Full Text] [Related]
7. Serum leptin levels after bariatric surgery across a range of glucose tolerance from normal to diabetes.
Geloneze B; Tambascia MA; Pareja JC; Repetto EM; Magna LA; Pereira SG
Obes Surg; 2001 Dec; 11(6):693-8. PubMed ID: 11775566
[TBL] [Abstract][Full Text] [Related]
8. The Clamp-Like Index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects.
Anderwald C; Anderwald-Stadler M; Promintzer M; Prager G; Mandl M; Nowotny P; Bischof MG; Wolzt M; Ludvik B; Kästenbauer T; Pacini G; Luger A; Krebs M
Diabetes Care; 2007 Sep; 30(9):2374-80. PubMed ID: 17595351
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of subcutaneous recombinant methionyl human leptin administration in healthy subjects in the fed and fasting states: regulation by gender and adiposity.
Chan JL; Wong SL; Mantzoros CS
Clin Pharmacokinet; 2008; 47(11):753-64. PubMed ID: 18840030
[TBL] [Abstract][Full Text] [Related]
10. Acute effect of roux-en-y gastric bypass on whole-body insulin sensitivity: a study with the euglycemic-hyperinsulinemic clamp.
Lima MM; Pareja JC; Alegre SM; Geloneze SR; Kahn SE; Astiarraga BD; Chaim EA; Geloneze B
J Clin Endocrinol Metab; 2010 Aug; 95(8):3871-5. PubMed ID: 20484482
[TBL] [Abstract][Full Text] [Related]
11. Decrease in circulating glucose, insulin and leptin levels and improvement in insulin resistance at 1 and 3 months after gastric bypass.
Ramos AP; de Abreu MR; Vendramini RC; Brunetti IL; Pepato MT
Obes Surg; 2006 Oct; 16(10):1359-64. PubMed ID: 17059747
[TBL] [Abstract][Full Text] [Related]
12. Improvement of insulin resistance and early atherosclerosis in patients after gastric banding.
Hanusch-Enserer U; Cauza E; Spak M; Endler G; Dunky A; Tura A; Wagner O; Rosen HR; Pacini G; Prager R
Obes Res; 2004 Feb; 12(2):284-91. PubMed ID: 14981221
[TBL] [Abstract][Full Text] [Related]
13. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome.
Ducluzeau PH; Cousin P; Malvoisin E; Bornet H; Vidal H; Laville M; Pugeat M
J Clin Endocrinol Metab; 2003 Aug; 88(8):3626-31. PubMed ID: 12915646
[TBL] [Abstract][Full Text] [Related]
14. The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery.
Nannipieri M; Mari A; Anselmino M; Baldi S; Barsotti E; Guarino D; Camastra S; Bellini R; Berta RD; Ferrannini E
J Clin Endocrinol Metab; 2011 Sep; 96(9):E1372-9. PubMed ID: 21778221
[TBL] [Abstract][Full Text] [Related]
15. Maternal pregravid weight is the primary determinant of serum leptin and its metabolic associations in pregnancy, irrespective of gestational glucose tolerance status.
Maple-Brown L; Ye C; Hanley AJ; Connelly PW; Sermer M; Zinman B; Retnakaran R
J Clin Endocrinol Metab; 2012 Nov; 97(11):4148-55. PubMed ID: 22948759
[TBL] [Abstract][Full Text] [Related]
16. Congenital leptin deficiency: diagnosis and effects of leptin replacement therapy.
Paz-Filho G; Mastronardi C; Delibasi T; Wong ML; Licinio J
Arq Bras Endocrinol Metabol; 2010 Nov; 54(8):690-7. PubMed ID: 21340154
[TBL] [Abstract][Full Text] [Related]
17. Effect of leptin replacement on brain structure in genetically leptin-deficient adults.
Matochik JA; London ED; Yildiz BO; Ozata M; Caglayan S; DePaoli AM; Wong ML; Licinio J
J Clin Endocrinol Metab; 2005 May; 90(5):2851-4. PubMed ID: 15713712
[TBL] [Abstract][Full Text] [Related]
18. Skeletal muscle insulin resistance in morbid obesity: the role of interleukin-6 and leptin.
Mitrou P; Lambadiari V; Maratou E; Boutati E; Komesidou V; Papakonstantinou A; Raptis SA; Dimitriadis G
Exp Clin Endocrinol Diabetes; 2011 Sep; 119(8):484-9. PubMed ID: 21811961
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of metformin in normoglycemic morbidly obese adolescents.
Kay JP; Alemzadeh R; Langley G; D'Angelo L; Smith P; Holshouser S
Metabolism; 2001 Dec; 50(12):1457-61. PubMed ID: 11735093
[TBL] [Abstract][Full Text] [Related]
20. Discontinuation of hormone replacement therapy in young GH-treated hypopituitary women increases liver enzymes.
Høst C; Christiansen JJ; Christiansen JS; Jorgensen JO; Gravholt CH
Growth Horm IGF Res; 2010 Feb; 20(1):26-30. PubMed ID: 19660970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
